International Assets Investment Management LLC Raises Holdings in Revvity, Inc. (NYSE:RVTY)

International Assets Investment Management LLC increased its position in Revvity, Inc. (NYSE:RVTY) by 12,674.8% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 13,669 shares of the company’s stock after buying an additional 13,562 shares during the period. International Assets Investment Management LLC’s holdings in Revvity were worth $1,746,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in RVTY. Rothschild Investment LLC purchased a new stake in shares of Revvity during the 2nd quarter worth approximately $25,000. EverSource Wealth Advisors LLC raised its stake in Revvity by 74.2% during the second quarter. EverSource Wealth Advisors LLC now owns 392 shares of the company’s stock valued at $41,000 after purchasing an additional 167 shares in the last quarter. Fairfield Financial Advisors LTD bought a new position in Revvity during the second quarter valued at $43,000. Family Firm Inc. purchased a new position in shares of Revvity in the 2nd quarter worth $43,000. Finally, EntryPoint Capital LLC purchased a new stake in shares of Revvity during the 1st quarter valued at about $48,000. 86.65% of the stock is owned by institutional investors.

Revvity Stock Up 2.1 %

Shares of Revvity stock opened at $121.04 on Monday. Revvity, Inc. has a 1 year low of $82.17 and a 1 year high of $128.15. The company has a debt-to-equity ratio of 0.40, a current ratio of 2.27 and a quick ratio of 1.98. The stock has a market cap of $14.93 billion, a price-to-earnings ratio of 87.71, a PEG ratio of 3.27 and a beta of 1.06. The firm’s 50-day moving average is $121.39 and its two-hundred day moving average is $114.11.

Revvity Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, February 7th. Shareholders of record on Friday, January 17th will be given a dividend of $0.07 per share. The ex-dividend date of this dividend is Friday, January 17th. This represents a $0.28 annualized dividend and a yield of 0.23%. Revvity’s dividend payout ratio (DPR) is presently 20.29%.

Insider Buying and Selling at Revvity

In other news, insider Tajinder S. Vohra sold 2,153 shares of Revvity stock in a transaction that occurred on Monday, October 7th. The shares were sold at an average price of $122.09, for a total value of $262,859.77. Following the transaction, the insider now owns 23,960 shares of the company’s stock, valued at $2,925,276.40. The trade was a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. In related news, insider Joel S. Goldberg sold 3,500 shares of Revvity stock in a transaction that occurred on Wednesday, August 7th. The shares were sold at an average price of $117.86, for a total value of $412,510.00. Following the completion of the sale, the insider now directly owns 33,400 shares in the company, valued at $3,936,524. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider Tajinder S. Vohra sold 2,153 shares of the company’s stock in a transaction that occurred on Monday, October 7th. The shares were sold at an average price of $122.09, for a total transaction of $262,859.77. Following the transaction, the insider now owns 23,960 shares in the company, valued at $2,925,276.40. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 7,807 shares of company stock worth $937,576 over the last quarter. Insiders own 0.60% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities research analysts have weighed in on the company. TD Cowen boosted their price objective on Revvity from $130.00 to $141.00 and gave the stock a “buy” rating in a research note on Tuesday, July 30th. Barclays raised shares of Revvity from an “equal weight” rating to an “overweight” rating and lifted their price objective for the stock from $125.00 to $140.00 in a research note on Tuesday, October 15th. Bank of America increased their price objective on shares of Revvity from $118.00 to $127.00 and gave the stock a “neutral” rating in a research report on Tuesday, July 30th. Leerink Partners upped their target price on Revvity from $130.00 to $135.00 and gave the company an “outperform” rating in a research note on Thursday, October 17th. Finally, Wells Fargo & Company began coverage on Revvity in a research report on Tuesday, August 27th. They issued an “equal weight” rating and a $130.00 price objective on the stock. Seven investment analysts have rated the stock with a hold rating, eight have given a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $128.79.

Revvity Company Profile

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.